{
  "directed": true,
  "graph": {
    "annotation_list": {
      "MeasurementRelation": [
        "=",
        "~"
      ],
      "MeasurementType": [
        "IC50"
      ],
      "MeasurementUnits": [
        "μM"
      ]
    },
    "annotation_pattern": {
      "ArticleCompoundNumber": ".*",
      "Figure": ".*",
      "MeasurementRangeLower": ".*",
      "MeasurementRangeUpper": ".*",
      "MeasurementValue": ".*",
      "Page": ".*"
    },
    "annotation_url": {},
    "document_metadata": {
      "authors": "Charles Tapley Hoyt",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "A small assortment of academic articles describing quantitatively described interactions between the MAPT (Tau) protein and small molecules",
      "licenses": "CC BY 4.0",
      "name": "Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease",
      "version": "0.1.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/9a77ac1a02863bc48b04bab7e8fb0c1d1cec4dd0/external/chebi.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/9a77ac1a02863bc48b04bab7e8fb0c1d1cec4dd0/external/go.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/bulic2012.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "1": true
        },
        "Figure": {
          "4": true
        },
        "MeasurementRangeLower": {
          "1.9": true
        },
        "MeasurementRangeUpper": {
          "31": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "Page": {
          "D": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",
      "key": "d3ceb7a007fdcbefd2367a2e10f21ddb67ae123a46b7b1a7f314af2fdd7db16fcc48434c25422683067dafac0aa104f38acc188a1e5ce602baa12f9af63df629",
      "line": 57,
      "relation": "decreases",
      "source": 10,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "3": true
        },
        "Figure": {
          "4": true
        },
        "Page": {
          "D": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",
      "key": "f5869e878f56beb01e854c9e943a0f20eed88848c1210d1f1e84b6db99b020c3c43c4919e1c308048bd3ae422a4e9d00f9f9004869ee23c4ca69cccde94fc379",
      "line": 65,
      "relation": "causesNoChange",
      "source": 13,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "4": true
        },
        "Figure": {
          "4": true
        },
        "Page": {
          "D": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",
      "key": "61b4b60dac70a1b8eafab303add9abdb873fe7af1a86f3e2ea272cbedf42ee9b777d390eed59ad763987f8e13b7603294183b0517d36096093d0d49dd7859005",
      "line": 71,
      "relation": "causesNoChange",
      "source": 7,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "5": true
        },
        "Figure": {
          "4": true
        },
        "Page": {
          "D": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",
      "key": "4b76f714273a4900fdd515f68c6321929e0dea29513f7363f0875dd0b6dd6cb74d6b6bbe703bd2622c240e5d574dbbfc57c892964a8e390dab6b558404306f34",
      "line": 77,
      "relation": "causesNoChange",
      "source": 6,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "6": true
        },
        "Figure": {
          "4": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "MeasurementValue": {
          "2.6": true
        },
        "Page": {
          "D": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",
      "key": "1c3498745d85aedc705d7401cecddd718ed3119bc9b3e9964e9cdb36b7087b5572dc4acee03ec086473679d398aa99d7832a853aacb8d11ede176df88ce5fa5b",
      "line": 87,
      "relation": "decreases",
      "source": 14,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "7": true
        },
        "Figure": {
          "4": true
        },
        "MeasurementRelation": {
          "~": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "MeasurementValue": {
          "2": true
        },
        "Page": {
          "D": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",
      "key": "b1324ffff070b22b69ab315ad5b4a9480c97ae1f65d89bf14879e3fd62eb246debf8adce1242c85990e03555f890e2e81d212fe5105d4f7f8439e130757ed62b",
      "line": 97,
      "relation": "decreases",
      "source": 4,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "10": true
        },
        "Figure": {
          "6": true
        },
        "Page": {
          "F": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.",
      "key": "e9c9e5843284f65571f1b26fcdaa97651e08a92a893af8be04b6c8c3eae893d8101fda7369269bb120e52ea9275ccc27aabd1b96cf2cbe4b9bad46fa016087bf",
      "line": 115,
      "relation": "decreases",
      "source": 2,
      "target": 17
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "11": true
        },
        "Figure": {
          "6": true
        },
        "Page": {
          "F": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.",
      "key": "34da6bb0a0a1f593373dbcfb7a2224c0ab954c92a33c7c19c827487233f08d52e9cfcb5324d9b20f80b698bc4220960a371cd75096d141b1f8188d85fef8bb0e",
      "line": 121,
      "relation": "decreases",
      "source": 0,
      "target": 17
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "12": true
        },
        "Figure": {
          "6": true
        },
        "Page": {
          "F": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.",
      "key": "0d500149f7a59e60d299e0687598a7c7f40c9470ef2a8a8d917562981ba619678a72eba854334050afe0d744ee5ea4c36449493134ff6f82bde064b48f7e406d",
      "line": 127,
      "relation": "decreases",
      "source": 8,
      "target": 17
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "12": true
        },
        "Figure": {
          "8": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "MeasurementValue": {
          "1.8": true
        },
        "Page": {
          "H": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Pyrogallol generic substitution pattern commonly found in multiple polyphenolic Tau aggregation inhibitors such as 12 and 19. Note the structural overlap with the inactive pyrocatechol-substituted epicatechin",
      "key": "8674620938c3a10bc93851b17e025a67636997ab1e8c2ff03482dea28262c65e7629259e5fd5de446ed2c81c08b28ec7a9aec3260ff3d738dbeacb8816069d05",
      "line": 163,
      "relation": "decreases",
      "source": 8,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "13": true
        },
        "Figure": {
          "6": true
        },
        "Page": {
          "F": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.",
      "key": "d980a2c3832c2de7b258e5ea6b97d66ab414ab7d356061d05992bdb7a109de1edbe421e07ecc9d00d44e53fee7e0604adfe7984a1694f0c5fa824134074be587",
      "line": 133,
      "relation": "decreases",
      "source": 11,
      "target": 17
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "14": true
        },
        "Figure": {
          "6": true
        },
        "Page": {
          "F": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.",
      "key": "5368f970b73fccfb808bb671ee82648f864473c6df516bc2ab4484e3a4939f7f8d87277aeeb1def35a10f96e7a510ea0f09399e04b98affe8c7b18d7721973bf",
      "line": 139,
      "relation": "decreases",
      "source": 20,
      "target": 17
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "14": true
        },
        "Figure": {
          "6": true
        },
        "Page": {
          "F": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Structures of Aβ-aggregation inhibitors evaluated in current or past clinical trials.",
      "key": "dd1193809fa4c0d2c7c9727d72325b6e63a66c149c3a5a7cc31f500386fe2d2f7046b388aef453391be39d564bf6d02ad6d77e74ad3f79f6302a3e020190d534",
      "line": 145,
      "relation": "decreases",
      "source": 18,
      "target": 17
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "18": true
        },
        "Figure": {
          "8": true
        },
        "Page": {
          "H": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Pyrogallol generic substitution pattern commonly found in multiple polyphenolic Tau aggregation inhibitors such as 12 and 19. Note the structural overlap with the inactive pyrocatechol-substituted epicatechin",
      "key": "e2391eee6c38f60c8c39318f00c79414d1a347a4a5b9f1819880409f3e45f100a46ca40bd31a3752e05a301c43cdad20b15b1c84e26a12490a529df8c9369c6a",
      "line": 169,
      "relation": "causesNoChange",
      "source": 15,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "19": true
        },
        "Figure": {
          "8": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "MeasurementValue": {
          "1.2": true
        },
        "Page": {
          "H": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Pyrogallol generic substitution pattern commonly found in multiple polyphenolic Tau aggregation inhibitors such as 12 and 19. Note the structural overlap with the inactive pyrocatechol-substituted epicatechin",
      "key": "ce54746fae846c401c0204bf2acaa12dbd3f5632e33c0ccfed317d0f31cdb679ad166dbec0ea2e1abd65e7b1b6de9eece26e3d2218e00f3f559ff81f44f81b52",
      "line": 179,
      "relation": "decreases",
      "source": 3,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "33": true
        },
        "Figure": {
          "12": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "MeasurementValue": {
          "30": true
        },
        "Page": {
          "K": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Representative examples of N-phenylamine Tau aggregation inhibitors and structural overlap with the Aβ40 aggregation inhibitor 33 or the nonsteroidal anti-inflammatory drug 34.",
      "key": "59032292149853d641316faef7de48c9d21d3800018ad340aa950252c498de9a1d6ab1280bbb9b28ed30504b293e90cdf939989b32064b5ccf46ce28cd59adad",
      "line": 219,
      "relation": "decreases",
      "source": 5,
      "target": 17
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "33": true
        },
        "Figure": {
          "12": true
        },
        "Page": {
          "K": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Representative examples of N-phenylamine Tau aggregation inhibitors and structural overlap with the Aβ40 aggregation inhibitor 33 or the nonsteroidal anti-inflammatory drug 34.",
      "key": "4be72d495a7594360ced3668f3b33e4239fea278faa5ca920e0da9ebae1665b433cfd11eced6f3e61139b47c00b13adee000006742fcf79d5bbaff60c92658ed",
      "line": 222,
      "relation": "decreases",
      "source": 5,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "34": true
        },
        "Figure": {
          "12": true
        },
        "Page": {
          "K": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Representative examples of N-phenylamine Tau aggregation inhibitors and structural overlap with the Aβ40 aggregation inhibitor 33 or the nonsteroidal anti-inflammatory drug 34.",
      "key": "55223de8e9506be67b5935b52180f1edda56ee183ed2af871511abdd4de47630d0a7cf7dd6d4cb6354caae6a1297dbfbce5b8799f57ed1a34b6eb5024d1a2412",
      "line": 228,
      "relation": "decreases",
      "source": 9,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "34": true
        },
        "Figure": {
          "12": true
        },
        "Page": {
          "K": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Representative examples of N-phenylamine Tau aggregation inhibitors and structural overlap with the Aβ40 aggregation inhibitor 33 or the nonsteroidal anti-inflammatory drug 34.",
      "key": "6f8a2cb354bd4d37cb75f934d877e861d9274119d5fb9f680e2cf0345a1c2f050154ebe487e9332d77ed137b03a53ff197cae86a48c48db451d8be3a45e7d1d5",
      "line": 229,
      "relation": "decreases",
      "source": 9,
      "target": 17
    },
    {
      "key": "28b28667c20344194dc827e3ba5f1ea5cc88530ea58db0a30c262cd4c51b4a25397ad027b715e077e80d7efdc0ea3883a1b5c053c5551642d65201847f6fb0a8",
      "relation": "hasComponent",
      "source": 22,
      "target": 12
    },
    {
      "key": "ee253cf9a6ae23ef4a4806c95ee6ea4ee3dcc3d0400e590b81eff4b5ea39f68f831cc06c05014454f6e19cbcc9b628df5e1cd6e46cab7a8b25a4e86b63764a5e",
      "relation": "hasComponent",
      "source": 22,
      "target": 21
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "41": true
        },
        "Figure": {
          "14": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "MeasurementValue": {
          "5.1": true
        },
        "Page": {
          "L": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Aminothienopyridazines (APTZs) Tau aggregation inhibitors (B/P: blood to plasma ratio).",
      "key": "5995a82834011d76713dab0f9aff97f62c0562ae76c6b9bd59a0656d37c54be43f7af780e377fbc187a07b8db52a31fc82e525a3e30bef3a866b5728911420b1",
      "line": 272,
      "relation": "decreases",
      "source": 1,
      "target": 16
    },
    {
      "annotations": {
        "ArticleCompoundNumber": {
          "41": true
        },
        "Figure": {
          "14": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "IC50": true
        },
        "MeasurementUnits": {
          "μM": true
        },
        "MeasurementValue": {
          "6.3": true
        },
        "Page": {
          "L": true
        }
      },
      "citation": {
        "authors": [
          "Bulic B",
          "Mandelkow E",
          "Pickhardt M"
        ],
        "date": "2013-06-13",
        "first": "Bulic B",
        "last": "Mandelkow E",
        "name": "Journal of medicinal chemistry",
        "pages": "4135-55",
        "reference": "23484434",
        "title": "Progress and developments in tau aggregation inhibitors for Alzheimer disease.",
        "type": "PubMed",
        "volume": "56"
      },
      "evidence": "Aminothienopyridazines (APTZs) Tau aggregation inhibitors (B/P: blood to plasma ratio).",
      "key": "de0840fccfd052d8e451028a84f5b655a70b58b789712bc560db28b561e1d2c5d912b095d5346ab3c11ffd73315c46c74c04f73fbd8d941f13fbe6f8dc3e401b",
      "line": 282,
      "relation": "decreases",
      "source": 19,
      "target": 16
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:10642)",
      "function": "Abundance",
      "id": "03a1ca7d8da603094ff9ecf327c24de8067ca96dc0ef6b31102cfbe2b8bc625f1ed80a74eabb6c60189cdffbf752dc909fa41c4b3b43e116547043760121c8d7",
      "name": "10642",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:112284)",
      "function": "Abundance",
      "id": "2383c791b89eaa1b20e4bec16a7f8ba79f116c892e711cb8bbcb73ee1a42c9b89ff745a346fd67be3e34540dcda9d1fea05c3bb5f9d0b012f342d8b6897374c5",
      "name": "112284",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:1457)",
      "function": "Abundance",
      "id": "f6001f6210fa2474cd8bfe9766b3658e915a2ad8d82debb1214d91ed2aece377ff30c7f7ea29c203a9b9d4d024d9f625292e8283939c34a84f52c2243d785888",
      "name": "1457",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:18152)",
      "function": "Abundance",
      "id": "2b0c5802f948265c6627fdd01cf1d016297a0812b4528a184e6435ed5701870be7016b89d8b3f326d2a54e99dbcffa997255e4dcd3db4f59d8048b77ccda47c8",
      "name": "18152",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:22580)",
      "function": "Abundance",
      "id": "150eb8f16ffda43dfa27f2b9287b57321752a9f06bbdf60d176ce81abbcab30f2429598968ad5dc1d93b4a8d6cbff3379cb63e75305bf4214aaf889e37f60d8a",
      "name": "22580",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:3441)",
      "function": "Abundance",
      "id": "33718cd54990be71dd45f60a78e8872f036cc058549e6ef1b16eeaa420b1143129fa1db096fa6c61b06f45235b356edbdf2a23924bd63e1197cef52ad8a9c936",
      "name": "3441",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:3647)",
      "function": "Abundance",
      "id": "3811308d2d2c98a77d7eeaf63fe8a2d843401c38ef763021c63f6ca32601aa200ccb84ff18af29ef0aab71a306f82fe6b093fd955b2dbc9be6fd6b557c69cce8",
      "name": "3647",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:44932)",
      "function": "Abundance",
      "id": "cc9444fc4d98eef6538d8814b9c0cfb4fc1ecc7dc01afae658ab6dc3afdbf51be2e4753f7cb2c36b322576c7d24daffacc93c27b5219c727a556b8ab47a8d5cd",
      "name": "44932",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:4806)",
      "function": "Abundance",
      "id": "15a0a316e15040d0368bc57beb56dce0a981ba71706f4831396e2b47794b05b7561117513f9fea9068b0866e51cdfc1f910be227f460697b6ff35d6515109c8a",
      "name": "4806",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:6710)",
      "function": "Abundance",
      "id": "7526fc8ffd1fa031fbd09ea85655b4fbf507d04ae64ca5f4809d884a9dcf63987b6e23f37e560b42e33a45a82cea15c25585f6a7d635bdc3d9163d4c453ca397",
      "name": "6710",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:6872)",
      "function": "Abundance",
      "id": "db35458fdf2ccd61b0e147e8e8b3067051fc9c60269c00ee0c6151c30128488b325d8986c2d8c072fbed4439af90ba24e5e231d3e0888a77b4ea9b4706416417",
      "name": "6872",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:74460)",
      "function": "Abundance",
      "id": "dbab548db21cbc88b1da0c63c5afbbfc3d6509f21e8117d185e8f90a0d54e6cb07034f816c879300c4aa7d30e41c0e73c878eb20ba7b9c87fe1dde6c871ed11f",
      "name": "74460",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:76034)",
      "function": "Abundance",
      "id": "96c3dc259554904457cd50b9cde9568bb354e50672c6fdd6af581ab9e4cd4c108b2290c4d2621df5b17c68a4e6ea61adf4d89cbba40c56195d78c1639f969817",
      "name": "76034",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:8028)",
      "function": "Abundance",
      "id": "029d75b7582d24d76d8554826ac173a0b417f54964405cc85f06dc9a520f07fdc39ed835753440e5ea62d64adfd074fd154eb717a75f1801a65815f3877fafd6",
      "name": "8028",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:87637)",
      "function": "Abundance",
      "id": "61962819e69554d965b6811f6aeb27bb58e1c1046b6af7a4a47d795d6359bec4fe09cbf743e4d0a65192e2825c92deb504b7d70278326f4cfc73cdc51027a2d1",
      "name": "87637",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:90)",
      "function": "Abundance",
      "id": "bd576a55d1ad28c0af16415d17e6473902be031b0a935e9a33ca386a41becaf29307cfc92c474506d3cb3745a1dc727406d3fc950416bf75fe0987217edfeba0",
      "name": "90",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CONSO:CONSO00006)",
      "function": "Abundance",
      "id": "625c9b3f11293713687baa89780284f1f974691d8c754a66b60498afc2a289c2ad8ebc02ddc9de3ccb454092deef215d60e77b3a8cb8c4126b52c755bc9b2041",
      "name": "CONSO00006",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00018)",
      "function": "Abundance",
      "id": "03851dfd7175733b6351f4ebbc7209b124a5f9252b750089760cfbce516ab1044d662f2e161bef80676c4a9ee4274c54687287f6cc5fe54523326e97a130a444",
      "name": "CONSO00018",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00019)",
      "function": "Abundance",
      "id": "ab2bb4496a4d327446d8b17f44b1f5da39b32bfcd6181f6d4e2c1eb2545b5648d2ecce16b35e7f3737ec899f73d76729e45b5524b324ce7b4b0b206ca7317b5f",
      "name": "CONSO00019",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00020)",
      "function": "Abundance",
      "id": "623af43ffa696f991095c1f23d73e59eef3d5c130155d0a45ca36f17e2fc030e2a637f2b76c8c282c29677b4d0993b78967852c6faeda94e2ef2efb647375173",
      "name": "CONSO00020",
      "namespace": "CONSO"
    },
    {
      "bel": "a(CONSO:CONSO00021)",
      "function": "Abundance",
      "id": "b7e15064885e0217b04ac8ef1b185ec8b2fa9f030c451a37fb72322b7808f2030a83868a439c278104ab98698fc53751015ff65e574cc26c2fd868e0f7eee294",
      "name": "CONSO00021",
      "namespace": "CONSO"
    },
    {
      "bel": "a(GO:\"GO:0097418\")",
      "function": "Abundance",
      "id": "fdc92577af09f60fa3b05c796780c4a6131db9f614468c7a6c234636af16b78631a2cc89aa49f145a715e3e445cfdcc55d2551df3ae9bc56f3c179e453dba4bc",
      "name": "GO:0097418",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(CHEBI:76034), a(GO:\"GO:0097418\"))",
      "function": "Complex",
      "id": "2b69c9396e37e405b017a739ecbe1e7805e5571f083912d1a673cf01fd341851e73638077eb8622e79ec1698fbdcf3099449e015d9f788810628e6f10329381b",
      "members": [
        {
          "bel": "a(CHEBI:76034)",
          "function": "Abundance",
          "id": "96c3dc259554904457cd50b9cde9568bb354e50672c6fdd6af581ab9e4cd4c108b2290c4d2621df5b17c68a4e6ea61adf4d89cbba40c56195d78c1639f969817",
          "name": "76034",
          "namespace": "CHEBI"
        },
        {
          "bel": "a(GO:\"GO:0097418\")",
          "function": "Abundance",
          "id": "fdc92577af09f60fa3b05c796780c4a6131db9f614468c7a6c234636af16b78631a2cc89aa49f145a715e3e445cfdcc55d2551df3ae9bc56f3c179e453dba4bc",
          "name": "GO:0097418",
          "namespace": "GO"
        }
      ]
    }
  ]
}